Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

NCT02680847 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was terminated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.

Conditions

Interventions

Sponsor

Pfizer